Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXWS9K
|
||||
| Drug Name |
1-phenyl-3-(4-(pyridin-2-yl)piperazin-1-yl)propan-1-one
|
||||
| Synonyms |
CHEMBL135023
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C18H21N3O
|
||||
| Canonical SMILES |
O=C(CCN1CCN(CC1)c2ccccn2)c3ccccc3
|
||||
| InChI |
InChI=1S/C18H21N3O/c22-17(16-6-2-1-3-7-16)9-11-20-12-14-21(15-13-20)18-8-4-5-10-19-18/h1-8,10H,9,11-15H2
|
||||
| InChIKey |
BQRNMHGSNMYICH-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.